Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02924922Completed
Randomised, open-label trial (2 arms), sponsored by Luzerner Kantonsspital. Primary endpoint: Change of Scintigraphic Split Renal Function at 6 months. Started May 2016; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02924922.